RRMS patients also display significantly diminished cytokine-driven accumulation of IFN-γ-producing CD56bright NK cells in the blood, a marker for NK cells possessing increased regulatory function [154]. Here, IFNG is linked to relapsing-remitting multiple sclerosis.